Pegasys (pegylated interferon alfa-2a)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Pegasys (pegylated interferon alfa-2a), covering 2010-10-25 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO) [Phase 2]